James Parslow
Vorstandsvorsitzender bei XENETIC BIOSCIENCES, INC.
Vermögen: - $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Scott Maguire | M | 61 |
Lipoxen Technologies Ltd.
 Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK.
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 20 Jahre |
| Colin William Hill | M | 79 |
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK.
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 Jahre |
| Adam Logal | M | 46 | 7 Jahre | |
| Dmitriy Genkin | M | 56 | 5 Jahre | |
| Roger Kornberg | M | 76 | 8 Jahre | |
| Firdaus Jal Dastoor | M | 72 | 10 Jahre | |
| Alexey Vinogradov | M | 54 | 5 Jahre | |
| James Callaway | M | 68 | 7 Jahre | |
| Grigory Borisenko | M | 55 | 5 Jahre | |
| Moshe Mizrahy | M | 71 | - | |
| Sanjay Jain | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 23 Jahre |
| Brad Marcus | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 Jahre |
| Henry Hoppe | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 12 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Philip V. Adams | M | 66 | 12 Jahre | |
| Peter Londa | M | 51 | 1 Jahre | |
| Edward T. Libbey | M | 77 | 16 Jahre | |
| Richard M. Domaleski | M | 54 | 16 Jahre | |
| Jeffrey Eisenberg | M | 58 | 8 Jahre | |
| Dave Laipple | M | - | - | |
| Curtis Lockshin | M | 64 | 10 Jahre | |
| Patrick R. Bischoff | M | 55 | 9 Jahre | |
| David B. Brewster | M | 52 | - | |
| Thad A. Wolfe | M | 81 | 8 Jahre | |
| Ralph S. Sheridan | M | 73 | 2 Jahre | |
| Sean S. Sweeney | M | 66 | 1 Jahre | |
| Neil Moses | M | - | - | |
| John W. Wellard | M | 76 | 8 Jahre | |
| Roman Sergeevich Knyazev | M | 44 | 5 Jahre | |
| Dan May | M | - | - | |
| Tony Barnhart | M | - | - | |
| Darlene Deptula-Hicks | F | 66 | 3 Jahre | |
| Martha Danly | M | 70 | - | |
| William Wiegler | M | - | - | |
| Edward Benz | M | 78 | 1 Jahre | |
| Carolyn Oldenburg | F | - | - | |
| John C. Fox | M | 75 | 1 Jahre | |
| Eric G. Alam | M | - | 2 Jahre | |
| Timothy G. Healy | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 34 | 89,47% |
| Vereinigtes Königreich | 5 | 13,16% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- James Parslow
- Persönliches Netzwerk
